Navigation Links
OncLive Expands Its Strategic Alliance Partnership Program With the Addition of UNC Lineberger Comprehensive Cancer Center
Date:7/23/2014

Plainsboro, N.J. (PRWEB) July 23, 2014

OncLive® is pleased to announce that UNC Lineberger Comprehensive Cancer Center has joined its Strategic Alliance Partnership program.

By participating in the Strategic Alliance Partnership program, UNC Lineberger will have the opportunity to work with the OncLive team to raise awareness of its cutting-edge research initiatives, community-directed cancer prevention programs, and other projects. Experts from UNC Lineberger will work with OncLive to educate their peers by providing insights and analysis on the latest news and discoveries in oncology.

UNC Lineberger is a National Cancer Institute-designated comprehensive cancer center, one of only 41 such organizations in the country, and has been providing multidisciplinary, patient-centered care for more than a quarter century. The clinicians and researchers at UNC Lineberger have also been at the forefront of applying advanced technologies such as Intensity Modulated Radiation therapy, Intraoperative Radiation Therapy, and robotic surgery in the treatment of cancer.

In addition to leading important cancer epidemiology and cancer prevention and control programs that examine patterns of cancer in the community to understand the complex interaction among genetics, biology, environmental exposures and behaviors that cause cancer, UNC Lineberger researchers and clinicians also run research programs in Cancer Cell Biology, Immunology, Molecular Carcinogenesis, Cancer Genetics, Molecular Therapeutics, and Virology that investigate the molecular and genetic basis of cancer and progression.

Mike Hennessy, Jr., Vice President of Sales and Marketing and leader of the oncology division of Intellisphere, the publisher of OncLive, said, “UNC Lineberger Comprehensive Cancer Center is an internationally recognized and respected leader in comprehensive cancer research, treatment, and support. We are excited and honored
'/>"/>

Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Yale Cancer Center Joins OncLive's Strategic Alliance Partnership
2. Particle Sciences Expands Biopharmaceutical Development Infrastructure
3. Ajinomoto Group Expands Cysteine Derivatives Production Capacity
4. Terascala Expands Executive Team
5. Spark Therapeutics Expands Leadership Team to Support Development and Commercialization of its Late-Stage Gene Therapy Pipeline
6. 5W Public Relations Expands Corporate Practice, Adds PURE Bioscience, Inc. to Client Roster
7. Rubicon Genomics Expands Distribution in Europe and Asia
8. SoundConnect Expands Distribution of Adobe Connect Event Module
9. New Monol Oligomer Technology Expands Applications for Cray Valley’s Krasol Additives
10. Edison Expands its European Pharmaceutical Coverage by Initiating on MagForce
11. ImaginAb Expands Scientific Advisory Board
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2015)... LAUDERDALE, Fla. , Feb. 26, 2015 ... discussed growth priorities driven by key research advancements and ... segments at today,s Bank of America Merrill Lynch 2015 ... met the challenge of building grain supplies the last ... to continue at the pace of the last decade, ...
(Date:2/26/2015)... 2015 The healthcare landscape is rapidly and radically ... Sullivan will host its 20 th Anniversary Medical ... 8 to 10, at the Hilton San Diego Resort and ... This event is a platform for global medical devices, ... disruptions and how to succeed in an uncertain future. ...
(Date:2/26/2015)... Innovation is more urgent than ever. Radical ... the world and transforming global markets in industry ... health care, disruption is constantly underway. , As ... shake the foundations of established business models, large-scale ... survive the next wave of mega-change. , This ...
(Date:2/26/2015)... February 26, 2015 Regis Technologies ... development of oncology drug substances. , Regis Technologies is ... their new Potent Compound Suite (PCS) for 2015. , ... square foot, cGMP facility in Morton Grove, Illinois. The ... of potent compounds up to about one kilogram per ...
Breaking Biology Technology:DuPont Leader Outlines Path for Growth in Agriculture and Nutrition & Health Segments 2DuPont Leader Outlines Path for Growth in Agriculture and Nutrition & Health Segments 3DuPont Leader Outlines Path for Growth in Agriculture and Nutrition & Health Segments 4DuPont Leader Outlines Path for Growth in Agriculture and Nutrition & Health Segments 5Embrace the Future of Medical Technologies with Frost & Sullivan 2Embrace the Future of Medical Technologies with Frost & Sullivan 3One Million Acts of Innovation Canada Creates Partnership with The Economist Events’ Innovation Forum 2Regis Extends cGMP Services to Oncology Market 2
... Trial in Medullary Thyroid Cancer Planned to Initiate ... 16 ,Exelixis, Inc. (Nasdaq: EXEL ) announced ... Drug Administration (FDA) have reached agreement on the ... anticancer compound targeting,MET, RET, and VEGFR2, via the ...
... Thermage Inc. To, Drive Coapt,s Growth In ... June 13 Coapt Systems, Inc.,developer of bioabsorbable implants ... and sports medicine markets, announced today the,appointment of Laureen ... as a member of the company,s Board of Directors. ...
... landmark IRIS trial, which established Gleevec as standard ... of care, - Study did not ... molecular responses with 800 vs. 400 ... optimize treatment benefit for individual ...
Cached Biology Technology:Exelixis Reaches Agreement with FDA on Special Protocol Assessment for XL184 Phase 3 Trial 2Exelixis Reaches Agreement with FDA on Special Protocol Assessment for XL184 Phase 3 Trial 3Exelixis Reaches Agreement with FDA on Special Protocol Assessment for XL184 Phase 3 Trial 4Exelixis Reaches Agreement with FDA on Special Protocol Assessment for XL184 Phase 3 Trial 5Coapt Systems New CEO, Laureen DeBuono, to Fuel Company's Growth and Product Innovation 2Coapt Systems New CEO, Laureen DeBuono, to Fuel Company's Growth and Product Innovation 3Video: Higher Initial Dose of Gleevec Achieved Better Early Responses than Standard Dose for Patients with Chronic Myeloid Leukemia 2Video: Higher Initial Dose of Gleevec Achieved Better Early Responses than Standard Dose for Patients with Chronic Myeloid Leukemia 3Video: Higher Initial Dose of Gleevec Achieved Better Early Responses than Standard Dose for Patients with Chronic Myeloid Leukemia 4Video: Higher Initial Dose of Gleevec Achieved Better Early Responses than Standard Dose for Patients with Chronic Myeloid Leukemia 5Video: Higher Initial Dose of Gleevec Achieved Better Early Responses than Standard Dose for Patients with Chronic Myeloid Leukemia 6Video: Higher Initial Dose of Gleevec Achieved Better Early Responses than Standard Dose for Patients with Chronic Myeloid Leukemia 7Video: Higher Initial Dose of Gleevec Achieved Better Early Responses than Standard Dose for Patients with Chronic Myeloid Leukemia 8Video: Higher Initial Dose of Gleevec Achieved Better Early Responses than Standard Dose for Patients with Chronic Myeloid Leukemia 9Video: Higher Initial Dose of Gleevec Achieved Better Early Responses than Standard Dose for Patients with Chronic Myeloid Leukemia 10Video: Higher Initial Dose of Gleevec Achieved Better Early Responses than Standard Dose for Patients with Chronic Myeloid Leukemia 11Video: Higher Initial Dose of Gleevec Achieved Better Early Responses than Standard Dose for Patients with Chronic Myeloid Leukemia 12Video: Higher Initial Dose of Gleevec Achieved Better Early Responses than Standard Dose for Patients with Chronic Myeloid Leukemia 13
(Date:1/22/2015)... 2015 NXT-ID, Inc. (NASDAQ: NXTD and NXTDW) a ... the recent success of the Wocket™ smart wallet at CES 2015 in ... was named as one of the "11 Hot Products at CES" in ... At CES So Far" by Newseveryday.com and "The top 10 gadgets from ...
(Date:1/22/2015)... , January 22, 2015 , ... year  The European Patent Office to present a video ... British nominations to be featured: Christofer Toumazou and ... former finalists and winners of the Award   Starting ...
(Date:1/22/2015)... has launched its new NXG series of time clocks with ... higher standard for collecting attendance and labor data and complements ... touch screen interface and seamless connection to cloud-based iSolved, the ... for the small to mid-size employer. The G2 ...
Breaking Biology News(10 mins):CES Response for NXT-ID's Wocket Smart Wallet Kicks Off 2015 2CES Response for NXT-ID's Wocket Smart Wallet Kicks Off 2015 3Ten Years of the European Inventor Award: A Retrospective Look at the Inventors and Ideas That Have Changed Our Lives 2Ten Years of the European Inventor Award: A Retrospective Look at the Inventors and Ideas That Have Changed Our Lives 3Infinisource's NXG series sets new time clock standard 2
... researchers have identified the neurocircuit that controls the brain's ... be possible to understand psychiatric disorders, such as anxiety ... brain. , They accomplished this using an adapted version ... that enables analysis of function in the brain. , ...
... the January/February 2007 issue of Physiological and Biochemical Zoology, ... may respond to water diversion and climate change. Endangered ... spawn, and a lake in Western China, where they ... and becoming increasingly more saline--leading to surprising adjustments to ...
... blood oxygen levels of a baby during labor--expected to ... benefit, report researchers in a National Institutes of Health ... saturation monitoring, was designed for use along with electronic ... measure changes in fetal oxygen levels. Designers of ...
Cached Biology News:Emotional control circuit of brain's fear response discovered 2Emotional control circuit of brain's fear response discovered 3Climate change has surprising effect on endangered naked carp 2Technology for monitoring fetal oxygen during labor offers no apparent benefit 2Technology for monitoring fetal oxygen during labor offers no apparent benefit 3
Request Info...
Mouse Galectin-1 Affinity Purified Polyclonal Ab...
EDG-1CT (endothelial cell differentiation gene-1, C terminal)...
Mouse monoclonal [MLM544] to cardiac Myosin light chain 1 ( Abpromise for all tested applications). entrezGeneID: 4634 SwissProtID: P08590...
Biology Products: